SAM
FOMX
Senzar Asset Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-67,429
| Closed | -$338K | – | 22 |
|
|
2018
Q2 | $338K | Buy |
+67,429
| New | +$338K | 0.98% | 22 |
|
|
2018
Q1 | – | Sell |
-377,397
| Closed | -$2.27M | – | 39 |
|
|
2017
Q4 | $2.27M | Sell |
377,397
-85,900
| -19% | -$516K | 0.58% | 28 |
|
|
2017
Q3 | $2.57M | Sell |
463,297
-105,900
| -19% | -$588K | 0.63% | 25 |
|
|
2017
Q2 | $2.64M | Sell |
569,197
-5,600
| -1% | -$26K | 0.65% | 22 |
|
|
2017
Q1 | $2.85M | Buy |
574,797
+23,800
| +4% | +$118K | 0.72% | 26 |
|
|
2016
Q4 | $6.12M | Buy |
550,997
+27,600
| +5% | +$306K | 1.62% | 19 |
|
|
2016
Q3 | $4.85M | Sell |
523,397
-75,000
| -13% | -$695K | 1.25% | 23 |
|
|
2016
Q2 | $3.8M | Sell |
598,397
-1,000,634
| -63% | -$6.35M | 0.83% | 30 |
|
|
2016
Q1 | $10.4M | Buy |
1,599,031
+101,600
| +7% | +$662K | 2.07% | 17 |
|
|
2015
Q4 | $12.1M | Buy |
1,497,431
+633,023
| +73% | +$5.13M | 1.35% | 21 |
|
|
2015
Q3 | $6.34M | Buy |
864,408
+156,959
| +22% | +$1.15M | 0.92% | 24 |
|
|
2015
Q2 | $7.25M | Buy |
707,449
+138,900
| +24% | +$1.42M | 1.25% | 29 |
|
|
2015
Q1 | $5.26M | Buy |
568,549
+55,900
| +11% | +$517K | 1.28% | 22 |
|
|
2014
Q4 | $3.59M | Buy |
+512,649
| New | +$3.59M | 1.05% | 28 |
|